期刊文献+

心脏型肌球蛋白结合蛋白CG416S突变导致肥厚型心肌病 被引量:1

Mutation G416S in Cardiac Myosin-binding Protein C Was Associated with Hypertrophic Cardiomyopathy
原文传递
导出
摘要 目的观察肥厚型心肌病(HCM)患者心脏型肌球蛋白结合蛋白CG416S突变导致肥厚型心肌病的特点。方法在100例HCM患者中对心脏型肌球蛋白结合蛋白C基因(MYBPC3)的所有外显子及其侧翼内含子序列进行基因扫描,聚合酶链反应(PCR)扩增目的片段,双脱氧末段终止法测序。分析携带基因突变患者的表型特点。结果在一例患者中发现MYBPC3第8697G>A基因突变,该突变位于外显子15,造成了心脏型肌球蛋白结合蛋白C第416位的甘氨酸转变成丝氨酸(G416S),该位置位于保守区。患者65岁时出现活动后胸痛不适,无高危因素。结论心脏型肌球蛋白结合蛋白CG416S错义突变能够导致HCM,携带该突变的患者表型轻、预后好。 Objective To describe the characteristics of hypertrophic cardiomyopathy associated with G416S mutation in cardiac myosin- binding protein C. Methods A systematic mutation screening of the whole exons and the adjacent introns of MYBPC3 gene was perfbrmed in 100 unrelated Chinese adult patients with HCM using direct DNA sequencing. The phenotype of the HCM patients was analyzed. Results A mutation (8697G〉A) located in the exon 15 of MYBPC3 was identified in a patient with HCM, which caused the reserved amino acid of Gln416 was changed to Ser. The patient expressed dyspnea or chest pain on exertion at 65 years of old without any identified high risk factors. Conclusion Mutation of G416S in cardiac myosin-binding protein C maybe caused HCM with benign outcome.
出处 《中国分子心脏病学杂志》 CAS 2013年第2期468-470,共3页 Molecular Cardiology of China
基金 国家自然基金面上项目(81070100)
关键词 肥厚型心肌病 心脏型肌球蛋白结合蛋白C G416S错义突变 表型 Hypertrophic Cardiomyopathy MYBPC3 Mutation Phenotype
  • 相关文献

参考文献11

  • 1Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest. 2010; 40:360-369.
  • 2Konno T, Chang S, Seidman JG, et al. Genetics of hypertrophic cardiomyopathy. Curl' Opin Cardiol. 2010; 25(3):205-209.
  • 3邹玉宝,王继征,吴格茹,宋雷,王曙霞,于晖,张芊,王虎,惠汝太.心脏型肌球蛋白结合蛋白C基因IVS15-1G>A突变导致肥厚型心肌病[J].中华心血管病杂志,2006,34(8):699-702. 被引量:3
  • 4王继征,邹玉宝,孙凯,王怡璐,王志民,高硕,周宪梁,惠汝太,宋雷.心脏肌球蛋白结合蛋白C基因18115_18116insGCAGG突变导致肥厚型心肌病特点分析[J].中国分子心脏病学杂志,2012,12(1):15-17. 被引量:1
  • 5王继征,张茵,王怡璐,孙凯,王志民,周宪梁,宋雷,惠汝太,邹玉宝.心脏型肌球蛋白结合蛋白C基因缺失突变导致肥厚型心肌病特点分析[J].中国分子心脏病学杂志,2012,12(2):92-94. 被引量:4
  • 6Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med. 2004; 116: 14-18.
  • 7Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287: 1308-1320.
  • 8Morita H, Rehm HL, Menesses A, et al. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med. 2008; 358: 1899-1908.
  • 9Winegrad S. Cardiac Myosin Binding Protein C. Circ Res. 1999; 84:1117-1126.
  • 10Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107:2227-2232.

二级参考文献32

  • 1Marian AJ.Hypertrophic cardiomyopathy:from genetics to treatment.Eur J Clin Invest.2010;40:360-369.
  • 2Konno T,Chang S,Seidman JG,Seidman CE.Genetics of hypertrophic cardiomyopathy.Curr Opin Cardiol.2010;25(3):205-209.
  • 3Winegrad S.Cardiac Myosin Binding Protein C.Circ Res.1999;84:1117-1126.
  • 4Watkins H,Conner D,Thierfelder L,et al.Mutations in the cardiac myosin binding protein-C gene on chromosome11cause familial hypertrophic cardiomyopathy.Nat Genet.1995;11(4):434-437.
  • 5Carrier L,Bonne G,B?hrend E,et al.Orgnization and sequence of human cardiac myosin binding protein C gene(MYBPC3)and identifi cation of mutations predicated to produce truncted proteins in familial hypertrophic cardiomyopathy.Circ res.1997;80:427-434.
  • 6Erdmann J,Raible J,Maki-Abadi J,et al.Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.J Am Coll Cardiol.2001;38:322-330.
  • 7American College of Cardiology Foundation/American Heart Association Task Force on Practice;American Association for Thoracic Surgery;American Society of Echocardiography;American Society of Nuclear Cardiology;Heart Failure Society of America;Heart Rhythm Society;Society for Cardiovascular Angiography and Interventions;Society of Thoracic Surgeons,Gersh BJ,Maron BJ,Bonow RO,et al.2011ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Thorac Cardiovasc Surg.2011;142(6):e153-203.
  • 8Seidman JG,Seidman CE.The genetic basis for cardiomyopathy:from mutation identification to mechanistic paradigms.Cell,2001,104:557-567.
  • 9Song L,Zou Y,Wang J,et al.Mutations profile in Chinese patients with hypertrophic cardiomyopathy.Clin Chim Acta,2005,351:209-216.
  • 10Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.

共引文献5

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部